An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.

NCT06511791 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

106

Enrollment

INDUSTRY

Sponsor class

Stopped This is a company decision made not related to safety concerns. Rather, it reflects a broader portfolio assessment and the desire to focus on programs that can bring timely and meaningful benefit to patients.

Conditions

Infertility

Interventions

DRUG: FE 999302
DRUG: Follitropin delta
DRUG: Placebo FE 999302

Sponsor

Ferring Pharmaceuticals